Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes

The aim of the present study was to manufacture new orally disintegrating tablets containing nimodipine–hydroxypropyl-β-cyclodextrin and nimodipine–methyl-β-cyclodextrin inclusion complexes. For obtaining a better quality of the manufactured tablets, three methods of the preparation of inclusion com...

Descripción completa

Detalles Bibliográficos
Autores principales: Novac, Marian, Musuc, Adina Magdalena, Ozon, Emma Adriana, Sarbu, Iulian, Mitu, Mirela Adriana, Rusu, Adriana, Gheorghe, Daniela, Petrescu, Simona, Atkinson, Irina, Lupuliasa, Dumitru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955142/
https://www.ncbi.nlm.nih.gov/pubmed/35335371
http://dx.doi.org/10.3390/molecules27062012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955142/
https://www.ncbi.nlm.nih.gov/pubmed/35335371
http://dx.doi.org/10.3390/molecules27062012

Ejemplares similares